Those investors who were able to stomach the declines during the Great Recession were rewarded handsomely over those investors who fled to "safer" bonds. You need to decide the returns that your retirement account requires to reach your goals. Likely, that will mean adding stocks to the portfolio.

 

Back to the target date funds, a look under the hood reveals that you may own more bonds than you thought.

 

JPMorgan SmartRetirement®
Year	Stocks  percent	Bonds  percent
2020	37 percent	63 percent
2030	61 percent	39 percent
2040	76 percent	24 percent
2050	83 percent	17 percent
2060	80 percent	20 percent

More bonds will make your retirement account less volatile, thereby giving you a smoother ride towards retirement. The price of that smooth ride will be the length of time it takes before you can comfortably retire. In the case of investing in target date funds, it may mean adding a few more years of working before you get to your destination. Are you OK with that?

 

Some people believe we are in a "melt-up." It is where the simple weight of money pouring into the U.S. stock market continues to carry stocks ever higher. Whether that qualifies as an investment thesis, or simply a lame excuse to justify record highs, it matters little to the bulls.

 

It is true that this past week, we actually witnessed a rare event — a two-day, 50-point drop in the S&P 500 Index — before stocks recovered.  But good news on Friday morning (job gains in the economy came in at 236,000) cheered investors. It was largely a goldilocks report where wage gains (considered inflationary) were flat for the month, bringing the the average hourly earnings rate up to 3.2 percent year-over-year.

 

Overall, the official U.S. unemployment rate is now 3.6 percent, which is the lowest level since 1969. It brings the total number of monthly job gains to 103 in a row, which has never happened before. Given that it is also the best start in the year for stocks since 1987, is there any wonder that exuberance is the prevailing mood on Wall Street (and in the White House)?

 

Even the bears, whose numbers are expanding by the way, admit that if we did suffer a correction, it would be, at most, shallow and sharp. That's the kind of correction you want, if and when it occurs. I have been reporting faithfully each week the bullish rise in investor sentiment and, although it remains flattish at 55.7 percent bulls, it is still quite high.

 

Earnings season, which is 80 percent complete, turned out to be better than expected in the minds of most investors.  And although the Fed did not cut interest rates this week at their FOMC meeting, I have to wonder if anyone really expected that to occur?

 

As we move into spring, it appears that the wall of worry we have been climbing is crumbling. We should finally receive a verdict on the U.S./China trade agreement as soon as next week, according to administration officials. Talks in China last week went well, and the Chinese delegation will be back in Washington this coming week to hammer out more details.

 

Some argue that a successful conclusion to this issue, which has been over-hanging the markets for almost two years, is largely discounted. Could we get a "sell on the news" reaction if a deal is announced?

 

We could, but I think it would depend on the level of the markets at the time. If, for example, the S&P 500 Index were to be trading above 3,000 or so, (another 70 points higher from here), then yes, it could be an excuse for some profit-taking.

 

And while everything seems rosy for the economy overall, we don't want it to get too much stronger in the short term. Remember, the Fed is data dependent. If, for example, the central bank did cut rates by a percentage point, as the president asks, in order to goose the economy, you can bet the next move by the Fed would be to reverse that and hike rates.

 

I believe the Fed's about face in interest rate policy last December is the real reason the market is where it is. If investors believed that the Fed's easy money policy might change, the markets would plummet. The Chinese economy might also be a factor.

 

In case you haven't realized this yet, China, as the world's second largest economy, has a substantial impact on overall global growth, including growth and inflation within the United States. Recently Chinese authorities have relied on fiscal spending to support their slowing economy, which has been hurt by the tariff issues.

 

A trade deal would be as good for China as it would be for the U.S. It could boost growth in both economies. But what's good for economies is not always good for stock markets. Rapid growth, on top of moderate growth, might ignite inflation.

 

In the past, Chinese demand for raw materials to fuel their growing economy has sparked inflation globally. If that were to happen again, it could force the Fed to reverse policy, raise rates, and cause a repeat of last year's sell-off. While this scenario is only one among several possibilities, it is something to keep in mind, given that we are within a week or two of a potential compromise solution in the trade talks.

 

Bill Schmick is registered as an investment adviser representative and portfolio manager with Berkshire Money Management (BMM), managing over $400 million for investors in the Berkshires.  Bill's forecasts and opinions are purely his own. None of the information presented here should be construed as an endorsement of BMM or a solicitation to become a client of BMM. Direct inquiries to Bill at 1-888-232-6072 (toll free) or email him at Bill@afewdollarsmore.com.

An initial public offering of a stock, called an IPO, can be either a sucker's game or a chance for instant riches. Determining the outcome requires a great deal of work, knowledge, and luck. Most investors have none of the above when it comes to IPOs.

 

I want to share with you a recent conversation I had with a conservative client (a vegetarian and yoga teacher) on this subject.

 

"I want to buy some stock of this company that makes a vegetarian form of hamburgers. How do I do it?" she asked.

 

"Why do you want to buy it?" I asked, before explaining the mechanics of such a purchase.

 

"Well, it tastes really good, all my friends love them, so I'm sure it's going to be a great stock since more and more people will switch to this healthy choice of food."

 

What's wrong with this picture?

 

No. 1, her analysis is full of holes. Her first mistake is failing to recognize three crucial differences. A good product does not necessarily translate to healthy corporate profits. Many a company with a good product has failed miserably because they did not have the knowledge, experience and financial acumen to make a go of it as a public company in a competitive marketplace.

 

No. 2, it does not necessarily follow that a company with good fundamentals will also perform well in the stock market. There are thousands of cases throughout financial history where companies that IPO never again reach their offering price.

 

And three, if you think it is hard enough to analyze the fundamental valuation and technical position of an already-established public company, imagine the difficulty in trying to do the same for a company with no historical data, and even worse, that sells a new or innovative product that is little understood.

 

Let's look at some of the other mistakes in financial logic my client is making. How many vegetarians are there in the U.S. versus meat eaters? The latest research (2017) put the number at 7.3 million Americans or 3.2 percent of the country's population. That's not a very big market, but she believes that once more people "discover" this non-meat burger, they too will find religion and give up meat.

 

Going public, however, won't change that. This particular company is already distributing its products (non-meat, non-chicken and non-sausage) in dozens of national food chains and stores throughout the nation and overseas.

 

She also needs to recognize that if this plant-based array of products is so good, competitors won't just sit still, they will imitate and offer their own plant-based products. In this case, it is already happening. Burger King is marketing a meatless "Impossible Burger." Reports indicate it is at least as tasty as my client's company's product.

 

Buyers of IPOs should also be aware that these offerings are normally handled by big brokerage houses that know how to promote a new issue and will, for a short time, support its price. Normally, brokers insist that company insiders have a "lock-up" period for a few months before owners and employees can sell their stock. When the lock-up period is over, an avalanche of sell orders hits the market. A look at most IPO stock prices a few months after going public shows a steep drop in price, most often well below the offering price.

 

Some retail investors don't care because they are planning to "flip" the stock. You buy the IPO after it begins to trade (usually at a higher price than the initial offering price), and then sell it for a profit over the next few days. That's where your luck comes in. Your odds of making money are equal to how much hype there is surrounding the stock.

 

Don't be fooled, some IPOs do skyrocket and never look back. You can take your chances, or have some patience, wait a few weeks or months and then, after doing your homework, make your investment. It's not as exciting, but it has been proven to be a better investment style over time.

 

Bill Schmick is registered as an investment adviser representative and portfolio manager with Berkshire Money Management (BMM), managing over $400 million for investors in the Berkshires.  Bill's forecasts and opinions are purely his own. None of the information presented here should be construed as an endorsement of BMM or a solicitation to become a client of BMM. Direct inquiries to Bill at 1-888-232-6072 (toll free) or email him at Bill@afewdollarsmore.com.

Cannabidiol is popping up all over the country. Local drug stores, supermarkets and health food shops, among other retailers, can't seem to get enough of this stuff on the shelves. Is this a fad, a fake, or does it have some real health benefits?

 

It's called CBD, for short, and this oil can be eaten, inhaled, and/or applied to the skin.  It is a substance extracted from the flowers and buds of the marijuana and hemp plant. And no, before you ask, you can't get high from it.  

 

Back in the day, (when I had hair to my shoulders, along with my buckskin jacket) I simply smoked marijuana or ate it in cookies. It contained THC. THC, a chemical, attaches to the CB1 receptors in the brain and triggers all those familiar sensations like increased appetite, giddiness, moods swings, etc.  Unlike THC, CBD was at first thought to attach to the CB2 receptors, which does not trigger psychoactive sensations. You don't get a buzz from it, although for someone like me that is no longer important.

 

The FDA allows CBD to be prescribed for epileptic seizure disorders and other ailments, but the research for other uses is till ongoing. Most consumers are using it for things like anti-inflammation and pain, especially for arthritis and injuries. Diabetes and acne are also conditions where CBD is used. Others believe it may have properties to treat Alzheimer's disease. Whether any of these claims are true, will be borne out in time through research.

 

Given my own arthritis issues, I decided not to wait to try it on my neck problems. It worked. The pain vanished for an entire day. I gave some to my neighbor, who has the same condition. It worked on him as well. Certainly, that is no scientific study, just personal experience. Now, what you should know is that CBD can be derived from both hemp and marijuana plants, which are similar, but not identical. Thanks to the Agricultural Improvement Act of 2018, hemp is now legal to grow and sell. Marijuana is not.  The CBD, which is derived from hemp is legal, as long as it contains less than 0.3 percent THC.

 

Sales of hemp-derived CBD oil four years ago was around $90 million. By next year, sales are estimated to top $450 million. If, over the next year or so, the federal government allows marijuana-derived CBD to be legally sold, the CBD market could generate as much as $1.2 billion in revenues.

 

CBD crystals are the purest form of the product. It can be dabbed, made into a tincture, or used as an edible by mixing it with high-fat foods. Topicals and salves can be sold as soap, lotions, even shampoos. It can be inhaled as a wax or inhaled as a vapor, as well as eaten in chocolates, baked goods, and even gummy bears. Pills and capsules are now marketed as nutritional supplements as well.

 

By the way, Titus, our ten-year-old Chocolate Lab, has been eating CBD-infused snacks for over two months now. Like me, Titus suffers from arthritis (me in the neck/back, him in both shoulders). Since he has many of the same brain receptors that I do, CBD works well on his arthritis as well

 

While pot stocks overall remain the darlings of the stock market, at least those companies that sell the legal form of CBD may have some real value. As for the companies that market the THC-based products, the risk is much higher. Under federal laws, growing and selling marijuana is not legal, at least until the U.S. government and more states pass new legislation that would legalize those products. That should happen within the next 12-18 months, according to both company managements as well as some legislators.

 

The stock market won't quit. It has been on a tear since the day after Christmas. It feels like it wants to keep climbing. That would be a fairly simple feat at this point, since we are only a percent or so away from regaining those historical highs. What will happen once we get there.?

 

You may ask why am I so confident that the markets won't just give up the ghost right here, right now? A look under the hood at the underlying sectors that make up the market indices gives me a clue. Let's take the semiconductor sector. Throughout the last year or more, semiconductors, a sub-segment of the technology area of the market, have led stocks higher (and lower) time and time again.

 

Semiconductors made a new all-time high this week. That usually precedes a similar move in the major indices.  In the case of the NASDAQ, we are within spitting distance of the old highs.

 

Other sectors, such as the Transportation Index — trains, planes, railroads, etc. — is nowhere near their historical highs, but that's not unusual. Another positive indicator is that just about all sectors are participating in this rally. The same is true overseas, where even the weak sister of the world, the Eurozone, is witnessing good gains within the European stock markets.

 

Over the last month, as readers are aware, I have repeatedly cautioned that somewhere out there lurks an expected pullback. Remember, we should expect 2-3 such pullbacks in the stock market each year at a minimum. It is the price of doing business in the stock market. A decline of as much as 9-10 percent would not be surprising, although I expect the next drop won't be of that magnitude.

 

In any case, as the markets climb, more and more equity experts that I respect are calling for a time out for the markets. Ned Davis, for example, runs a global research shop that is highly respected. He has a good number of years under his belt calling the twists and turns of the market. In his April research report he recommended that, "we would hold off adding equity allocation until a correction has taken place."

 

Davis worries that global fundamentals are deteriorating. "We will need to see evidence of improving fundamentals" before getting bullish again. Ned also points out that there has been a dangerous rise in complacency. The Ned Davis global sentiment indicators are registering the highest levels of optimism on record, dating back to 2002.

 

The US Advisory Sentiment Indicator, while not as high as the Ned Davis Index, still registered its highest reading in nine straight weeks of gains. It now stands at 54.8 percent, just shy of 55 percent, which indicates an elevated level of risk for the stock market.

 

Remember, however, that the investor sentiment contrary indicator is not the final say in whether the markets continue their run. We are now in the midst of the first quarter earnings season. So far, many of the company reports are coming in better than expected. As a result, despite the cautionary technical signals popping up in the markets, earnings and revenue "beats" are providing support for the bulls, at least for now. 

 

My advice is to just stay the course, since timing a pullback and getting back in would be just too tricky in this market. You would have more luck in Las Vegas, if you want to gamble.